The clinical-stage biotechnology company OneChain Immunotherapeutics, a member of CATALONIA.HEALTH, has announced the appointment of Barbara Krebs-Pohl as the new Chair of the Board of Directors. Barbara is a highly respected leader in the biotechnology sector with over 27 years of experience, particularly in business strategy and alliance development. Her appointment comes at a pivotal moment for OneChain, as the company enters its next phase of expansion.
Barbara Krebs-Pohl, new Chair of the Board of Directors at OneChain Immunotherapeutics, said: “I am thrilled to be joining OneChain at such an important stage, with first clinical signals from their frontrunner program in a phase 1 trial. The team’s deep expertise in applied science, coupled with a strong commitment to addressing urgent medical needs, makes this an exciting opportunity. I look forward to contributing to the company’s next steps in corporate development and helping to further advance their CAR T therapies and allogeneic platform.”
Stefanos Theoharis, CEO of OneChain Immunotherapeutics, also shared his excitement about Barbara’s new role, emphasizing the importance of her leadership in steering the company towards its future goals. Also, he added: “As our pipeline continues to evolve and deliver positive data and patient benefits, Barbara’s experience and proven track record in company growth, business development and strategic decision-making will be invaluable. I am very pleased to welcome Barbara as the new Chair of the BOD and to work closely with her for the continued success of our company.”
Laura Rodríguez, Board Member and Principal at Invivo Capital and Pablo Menendez, co-founder and CSO of OneChain Immunotherapeutics, also expressed their enthusiasm about the appointment, highlighting the significance of this new phase for the company: “We are delighted to welcome Barbara as Chair of the Board of Directors of OneChain. Her experience in strategic leadership and business development will be key to guiding its continued success.”
Comments